COL17A1 and neoplasm: The metastatic propensity signature (high COL17A1/PSMB8, low CTRC) suggests: PNI facilitation via collagen remodeling (COL17A1), immune-evasion priming through proteasomal antigen processing (PSMB8),protective trypsin depletion in tumor microenvironment (CTRC).